Last reviewed · How we verify
palliative care
At a glance
| Generic name | palliative care |
|---|---|
| Sponsor | OmicsWay Corp. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Living With Multimorbidity: Care Coordination and Symptom Management Program (COORDINATE) (NA)
- Evidence-Based Nursing Plus Progressive Exercise for Cancer-Related Fatigue in Advanced Lung Cancer (NA)
- Palliative Steroeotactic Body Radiotherapy vs Palliative Standard Radiotherapy in Patients With Advanced Head and Neck Cancer (PHASE3)
- User Testing of an End of Life Medication Support Intervention for Lay Carers (Palliate). (NA)
- Emotion and Symptom-Focused Engagement Trial for Individuals With Acute Leukemia (NA)
- Palliative Care for People With HF
- Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults (PHASE3)
- Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- palliative care CI brief — competitive landscape report
- palliative care updates RSS · CI watch RSS
- OmicsWay Corp. portfolio CI